Literature DB >> 33477869

Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice.

Pratima Kumari1, Hussin A Rothan1, Janhavi P Natekar1, Shannon Stone1, Heather Pathak1, Philip G Strate1, Komal Arora1, Margo A Brinton1, Mukesh Kumar1.   

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can cause neurological disease in humans, but little is known about the pathogenesis of SARS-CoV-2 infection in the central nervous system (CNS). Herein, using K18-hACE2 mice, we demonstrate that SARS-CoV-2 neuroinvasion and encephalitis is associated with mortality in these mice. Intranasal infection of K18-hACE2 mice with 105 plaque-forming units of SARS-CoV-2 resulted in 100% mortality by day 6 after infection. The highest virus titers in the lungs were observed on day 3 and declined on days 5 and 6 after infection. By contrast, very high levels of infectious virus were uniformly detected in the brains of all the animals on days 5 and 6. Onset of severe disease in infected mice correlated with peak viral levels in the brain. SARS-CoV-2-infected mice exhibited encephalitis hallmarks characterized by production of cytokines and chemokines, leukocyte infiltration, hemorrhage and neuronal cell death. SARS-CoV-2 was also found to productively infect cells within the nasal turbinate, eye and olfactory bulb, suggesting SARS-CoV-2 entry into the brain by this route after intranasal infection. Our data indicate that direct infection of CNS cells together with the induced inflammatory response in the brain resulted in the severe disease observed in SARS-CoV-2-infected K18-hACE2 mice.

Entities:  

Keywords:  COVID-19; K18-hACE2 mice; SARS-CoV-2; encephalitis; neuroinflammation; neuroinvasion

Mesh:

Substances:

Year:  2021        PMID: 33477869      PMCID: PMC7832889          DOI: 10.3390/v13010132

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  47 in total

1.  SARS-CoV-2 Infectivity and Neurological Targets in the Brain.

Authors:  Walter J Lukiw; Aileen Pogue; James M Hill
Journal:  Cell Mol Neurobiol       Date:  2020-08-25       Impact factor: 5.046

2.  Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of Type 2 diabetic mouse model infected with West Nile virus.

Authors:  Mukesh Kumar; Kelsey Roe; Pratibha V Nerurkar; Beverly Orillo; Karen S Thompson; Saguna Verma; Vivek R Nerurkar
Journal:  J Neuroinflammation       Date:  2014-04-21       Impact factor: 8.322

3.  A guinea pig model of Zika virus infection.

Authors:  Mukesh Kumar; Keeton K Krause; Francine Azouz; Eileen Nakano; Vivek R Nerurkar
Journal:  Virol J       Date:  2017-04-11       Impact factor: 4.099

4.  Multiorgan and Renal Tropism of SARS-CoV-2.

Authors:  Victor G Puelles; Marc Lütgehetmann; Maja T Lindenmeyer; Jan P Sperhake; Milagros N Wong; Lena Allweiss; Silvia Chilla; Axel Heinemann; Nicola Wanner; Shuya Liu; Fabian Braun; Shun Lu; Susanne Pfefferle; Ann S Schröder; Carolin Edler; Oliver Gross; Markus Glatzel; Dominic Wichmann; Thorsten Wiech; Stefan Kluge; Klaus Pueschel; Martin Aepfelbacher; Tobias B Huber
Journal:  N Engl J Med       Date:  2020-05-13       Impact factor: 91.245

5.  Z-DNA-Binding Protein 1 Is Critical for Controlling Virus Replication and Survival in West Nile Virus Encephalitis.

Authors:  Hussin A Rothan; Komal Arora; Janhavi P Natekar; Philip G Strate; Margo A Brinton; Mukesh Kumar
Journal:  Front Microbiol       Date:  2019-09-11       Impact factor: 5.640

6.  COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice.

Authors:  Jian Zheng; Lok-Yin Roy Wong; Kun Li; Abhishek Kumar Verma; Miguel E Ortiz; Christine Wohlford-Lenane; Mariah R Leidinger; C Michael Knudson; David K Meyerholz; Paul B McCray; Stanley Perlman
Journal:  Nature       Date:  2020-11-09       Impact factor: 49.962

7.  SARS-CoV-2 infects human neural progenitor cells and brain organoids.

Authors:  Bao-Zhong Zhang; Hin Chu; Shuo Han; Huiping Shuai; Jian Deng; Ye-Fan Hu; Hua-Rui Gong; Andrew Chak-Yiu Lee; Zijiao Zou; Thomas Yau; Wutian Wu; Ivan Fan-Ngai Hung; Jasper Fuk-Woo Chan; Kwok-Yung Yuen; Jian-Dong Huang
Journal:  Cell Res       Date:  2020-08-04       Impact factor: 25.617

8.  SARS-CoV-2 targets neurons of 3D human brain organoids.

Authors:  Anand Ramani; Lisa Müller; Philipp N Ostermann; Elke Gabriel; Pranty Abida-Islam; Andreas Müller-Schiffmann; Aruljothi Mariappan; Olivier Goureau; Henning Gruell; Andreas Walker; Marcel Andrée; Sandra Hauka; Torsten Houwaart; Alexander Dilthey; Kai Wohlgemuth; Heymut Omran; Florian Klein; Dagmar Wieczorek; Ortwin Adams; Jörg Timm; Carsten Korth; Heiner Schaal; Jay Gopalakrishnan
Journal:  EMBO J       Date:  2020-09-23       Impact factor: 11.598

9.  Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.

Authors:  Ludovico Cantuti-Castelvetri; Ravi Ojha; Liliana D Pedro; Minou Djannatian; Jonas Franz; Suvi Kuivanen; Franziska van der Meer; Katri Kallio; Tuğberk Kaya; Maria Anastasina; Teemu Smura; Lev Levanov; Leonora Szirovicza; Allan Tobi; Hannimari Kallio-Kokko; Pamela Österlund; Merja Joensuu; Frédéric A Meunier; Sarah J Butcher; Martin Sebastian Winkler; Brit Mollenhauer; Ari Helenius; Ozgun Gokce; Tambet Teesalu; Jussi Hepojoki; Olli Vapalahti; Christine Stadelmann; Giuseppe Balistreri; Mikael Simons
Journal:  Science       Date:  2020-10-20       Impact factor: 47.728

10.  SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.

Authors:  Emma S Winkler; Adam L Bailey; Natasha M Kafai; Sharmila Nair; Broc T McCune; Jinsheng Yu; Julie M Fox; Rita E Chen; James T Earnest; Shamus P Keeler; Jon H Ritter; Liang-I Kang; Sarah Dort; Annette Robichaud; Richard Head; Michael J Holtzman; Michael S Diamond
Journal:  Nat Immunol       Date:  2020-08-24       Impact factor: 31.250

View more
  67 in total

1.  Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice.

Authors:  Janhavi Prasad Natekar; Heather Pathak; Shannon Stone; Pratima Kumari; Shaligram Sharma; Tabassum Tasnim Auroni; Komal Arora; Hussin Alwan Rothan; Mukesh Kumar
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

2.  Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.

Authors:  Isabelle Dubuc; Julien Prunier; Émile Lacasse; Annie Gravel; Florian Puhm; Isabelle Allaeys; Anne-Sophie Archambault; Leslie Gudimard; Rosaria Villano; Arnaud Droit; Nicolas Flamand; Éric Boilard; Louis Flamand
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

3.  Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID.

Authors:  David A Holdsworth; Rebecca Chamley; Rob Barker-Davies; Oliver O'Sullivan; Peter Ladlow; James L Mitchell; Dominic Dewson; Daniel Mills; Samantha L J May; Mark Cranley; Cheng Xie; Edward Sellon; Joseph Mulae; Jon Naylor; Betty Raman; Nick P Talbot; Oliver J Rider; Alexander N Bennett; Edward D Nicol
Journal:  PLoS One       Date:  2022-06-10       Impact factor: 3.752

4.  A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses.

Authors:  Alberto A Amarilla; Julian D J Sng; Rhys Parry; Joshua M Deerain; James R Potter; Yin Xiang Setoh; Daniel J Rawle; Thuy T Le; Naphak Modhiran; Xiaohui Wang; Nias Y G Peng; Francisco J Torres; Alyssa Pyke; Jessica J Harrison; Morgan E Freney; Benjamin Liang; Christopher L D McMillan; Stacey T M Cheung; Darwin J Da Costa Guevara; Joshua M Hardy; Mark Bettington; David A Muller; Fasséli Coulibaly; Frederick Moore; Roy A Hall; Paul R Young; Jason M Mackenzie; Jody Hobson-Peters; Andreas Suhrbier; Daniel Watterson; Alexander A Khromykh
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 14.919

Review 5.  Zebrafish as a Translational Model: An Experimental Alternative to Study the Mechanisms Involved in Anosmia and Possible Neurodegenerative Aspects of COVID-19?

Authors:  Karla C M Costa; Tamires A V Brigante; Gabriel G Fernandes; Davi S Scomparin; Franciele F Scarante; Danielle P de Oliveira; Alline C Campos
Journal:  eNeuro       Date:  2021-06-02

Review 6.  SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models.

Authors:  G Kanimozhi; B Pradhapsingh; Charan Singh Pawar; Haseeb A Khan; Salman H Alrokayan; N Rajendra Prasad
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

7.  Sudden Sensorineural Hearing Loss in Mild COVID-19: Case Series and Analysis of the Literature.

Authors:  Filippo Ricciardiello; Davide Pisani; Pasquale Viola; Elisabetta Cristiano; Alfonso Scarpa; Antonio Giannone; Giuseppe Longo; Giuseppe Russo; Marco Bocchetti; Ciro Coppola; Marco Perrella; Flavia Oliva; Giuseppe Chiarella
Journal:  Audiol Res       Date:  2021-07-01

Review 8.  SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.

Authors:  Olivia Swain; Sofia K Romano; Ritika Miryala; Jocelyn Tsai; Vinnie Parikh; George K E Umanah
Journal:  J Neurosci       Date:  2021-06-23       Impact factor: 6.167

Review 9.  Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy.

Authors:  Qianqian Zhang; Rong Xiang; Shanshan Huo; Yunjiao Zhou; Shibo Jiang; Qiao Wang; Fei Yu
Journal:  Signal Transduct Target Ther       Date:  2021-06-11

Review 10.  Animal models of SARS-CoV-2 and COVID-19 for the development of prophylactic and therapeutic interventions.

Authors:  Marcel Renn; Eva Bartok; Thomas Zillinger; Gunther Hartmann; Rayk Behrendt
Journal:  Pharmacol Ther       Date:  2021-06-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.